The Next Wave Of GLP-1s: Why Slow And Steady Wins The Health Race
Summary
- Discover how new generations of GLP-1 drugs—dual and triple agonists—may outperform bariatric surgery in weight loss while supporting heart, brain, and kidney health
- Uncover why rushing peptide dosing can trigger hidden dangers like toxin dumps, fatigue, hair loss, and even rare cases of sudden blindness—and how to avoid them
- Learn how GLP-1s don’t just control appetite but actually rewire the brain’s reward centers, potentially reducing addiction while enhancing positive habits like exercise
- This video is part of the Bioregulators and Peptides Summit
